OpenBilldrug price receipt

NADAC week of 2026-10-14

MYDAYIS ER 12.5 MG CAPSULE

FDA nonproprietary name: dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate

For 30 capsules

Pharmacies pay

$322.78 filed

30 × $10.75933 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$376.20 estimated

$322.78 + $48.42 (15%) + $5.00 fee per fill = $376.20

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MYDAYIS ER 12.5 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate, under the trade name “MYDAYIS”.

FDA gives its dosage form as capsule, extended release and its route as oral.

The labeler, the company named on the label, is Takeda Pharmaceuticals America, Inc.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 54092-0468-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $322.78 for 30 capsules (30 × $10.75933 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $8.43593 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate with MYDAYIS ER 12.5 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
MYDAYIS ER 12.5 MG CAPSULE this page
brand · capsule, extended release
$10.75933 per EA filed
eff. 2026-09-23
We don’t know yet
MYDAYIS ER 25 MG CAPSULE
brand · capsule, extended release
$10.78837 per EA filed
eff. 2026-09-23
We don’t know yet
MYDAYIS ER 37.5 MG CAPSULE
brand · capsule, extended release
$10.75294 per EA filed
eff. 2026-09-23
We don’t know yet
MYDAYIS ER 50 MG CAPSULE
brand · capsule, extended release
$10.78273 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

Its NADAC price is $10.75933 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 68 have a higher middle NADAC price and 135 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.